Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is headquartered in Buenos Aires, Argentina.
Metrics to compare | RICHm | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRICHmPeersSector | |
---|---|---|---|---|
P/E Ratio | 21.1x | −1.0x | −0.6x | |
PEG Ratio | 0.12 | 0.01 | 0.00 | |
Price/Book | 1.5x | 1.2x | 2.6x | |
Price / LTM Sales | 2.1x | 1.2x | 3.2x | |
Upside (Analyst Target) | - | 88.5% | 46.5% | |
Fair Value Upside | Unlock | 13.6% | 6.6% | Unlock |